This activation triggers glucose-dependent insulin secretion, slows gastric emptying, and promotes satiety, leading to reduced caloric intake and improved glycemic control in both type 2 diabetes and weight management contexts
Recent studies suggest a potential link between GLP-1 receptor agonists and an increased risk of gallbladder disease
AEs in the trial were in line with the reported safety and tolerability profile of semaglutide 2.4 mg, with most reported as mild, transient and predominantly gastrointestinal-related
- Arterioscler Thromb Vasc Biol 29:184350 Laviola L, Leonardini A, Melchiorre M, Orlando MR, Peschechera A, Bortone A, Paparella D, Natalicchio A, Perrini S, Giorgino F (2012) Glucagon-like peptide-1 counteracts oxidative stress-dependent apoptosis of human cardiac progenitor cells by inhibiting the activation of the c-Jun N-terminal protein kinase signaling pathway